UNSPSC 51393305: Dexlofexidine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51393305

Definition

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VXJ7Z24RN1, chemically known as ( )-(s)-2-(1-(2,6-dichlorophenoxy)ethyl)-2-imidazoline but generally known as dexlofexidine, which bears US NIH Compound Identifier 208822. European Medicines Agency schedules Dexlofexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07035MIG. The term DEXLOFEXIDINE is an International Non-Proprietary Name.

Read the full definition

DEXLOFEXIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexlofexidine under HS 29332990 and SITC 51573. As of Q4 2014, DEXLOFEXIDINE remains the US FDA Preferred Term for this commodity. Dexlofexidine bears US NLM identifiers UMLS ID C2699612 and NCI Concept Code C77296. SMILES: CC(C1=NCCN1)OC2=C(C=CC=C2CL)CL.

About UNSPSC 51393305

UNSPSC 51393305 Dexlofexidine is a Commodity code that addresses pharmaceutical products used in emergency response and public health interventions, though the recent solicitation record shows limited direct purchasing activity under this specific code. State and local governments buy naloxone and drug deactivation systems under this classification to support community health and emergency services operations. The code serves health departments, county public health agencies, and community health organizations seeking opioid-response pharmaceuticals and related harm-reduction equipment. Procurement typically occurs through competitive bidding with multi-year terms and renewal options, and vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify authorization, and specified insurance coverage.

Seminole County, Florida, posted the most recent opportunity on this code on June 30, 2026 — an IFB (Solicitation Number IFB60459723LAS) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. The county requires quarterly deliveries to the Seminole County Community Health Building in Sanford, with vendors responsible for all shipping and delivery costs included in their bid. The initial contract term runs two years with a one-year renewal option, and potential FEMA funding introduces additional federal compliance obligations. Geographic activity on this code is limited; the single recent opportunity in the source block is anchored in Florida, and no other state or local solicitations appear in the recent record.

Quick answers

What is UNSPSC 51393305?

UNSPSC 51393305 is Dexlofexidine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51393305?

UNSPSC 51393305 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51393305

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code